HUTTON SCOTT (President & CEO) sold 3.0% of their position (1.49K shares) of BIODESIX INC on the open market
Open‑market sale worth $19.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2026ACC: 0000905148-26-000988
DirectorOfficer· President & CEO
Since Oct 2020
-1.49K
Net shares
Net seller
$19.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.84K acquired · 6.33K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.84K
Price / share
—
Trade value
—
% of position
10.7%
2/20/2026
45.41K→50.26K
Common Stock
Direct
Shares
−1.49K
Price / share
$12.78
Trade value
$19.04K
% of position
3.0%
2/23/2026
50.26K→48.77K
Total
Net shares
+3.35K
Net value
-$19.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | M · Option Exercise | +4.84K | — | — | 10.7% | 45.41K | 50.26K |
| Common Stock Direct | 2/23/2026 | S · Sale | −1.49K | $12.78 | $19.04K | 3.0% | 50.26K | 48.77K |
| Total | +3.35K | -$19.04K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
4.84K shares
Shares
−4.84K
Strike price
Held after
14.53K
Exercisable
—
2/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock4.84K shares | 2/20/2026 | M · Option Exercise | −4.84K | — | 14.53K |